AbbVie Inc. is 245.9x more valuable than PRECIGEN, INC. by market capitalization ($397.12 B vs $1.61 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PGEN | ABBV |
|---|---|---|
| Market cap | $1.61 B | $397.12 B |
| US-listed rank | #2268 | #30 |
| Revenue (latest FY) | $9.68M | $61.16B |
| Net income (latest FY) | -$250.60M | $4.23B |
| Net margin | -2587.8% | 6.9% |
| P/E (trailing FY) | - | 94.0 |
| SEC filings | 1,273 | 1,008 |
AbbVie Inc. is 245.9x more valuable than PRECIGEN, INC. by market capitalization ($397.12 B vs $1.61 B).
In their latest fiscal years, PRECIGEN, INC. reported $9.68M in revenue while AbbVie Inc. reported $61.16B.
Full pages: PRECIGEN, INC. and AbbVie Inc., or browse the full rankings.